Sarcopenia - Market Insights, Epidemiology and Market Forecast -2023-7 MM

Publisher Name :
Date: 31-Mar-2017
No. of pages: 51
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Sarcopenia - Market Insights, Epidemiology and Market Forecast-2023-7 MM" Report provides an overview of the disease and global market size of the Sarcopenia for the United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. It also includes historical and forecasted epidemiological data for the prevalent cases of Sarcopenia from 2013-2023.

Sarcopenia is the progressive loss of skeletal muscle that comes with aging. Sarcopenia is multifactorial in cause. Most people begin to lose modest amounts of muscle mass after age 30, but the resulting loss of strength increases exponentially with age. Of the contributory factors relating to the development of sarcopenia inadequate protein intake, increased splanchnic extraction of amino acids, decreased muscular response to postprandial anabolic stimuli and vitamin D deficiency are directly related to nutrition.

According to DelveInsight, the market size of Sarcopenia in 7 MM is estimated to be USD XX Million by 2023 at a CAGR of 2.36% for the forecast period i.e., 2013-2023. Also the prevalence cases in 7 MM are expected to increase and reach up to 42,969,489 cases by year 2023.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.

Scope

The report will help in developing business strategies by understanding the trends shaping and driving the Sarcopenia market.

Organize sales and marketing efforts by identifying the best opportunities for Sarcopenia in US, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan.

To understand the future market competition in the 7MM market of Sarcopenia and Insightful review of the key market drivers and barriers.

To understand the regulatory scenario in major markets.

The Report also covers the detailed historical and forecasted Sarcopenia market covering United States, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan from 2013-2023.

Sarcopenia - Market Insights, Epidemiology and Market Forecast -2023-7 MM

Table of Contents

Report Introduction
Sarcopenia: Overview
Introduction
Pathophysiology
Symptoms
Diagnosis
Sarcopenia categories and stages
EWGSOP Conceptual Stages of Sarcopenia
Treatment
Challenges
Unmet Need
Epidemiology of Sarcopenia in 7MM
Epidemiology and Patient Population
Assumptions and Caveats
Prevalent Population of Sarcopenia in 7MM
United States
Europe
United Kingdom
France
Italy
Spain
Germany
Japan
Pipeline Drugs in Development
Enobosarm: GTX, Inc.
Product Description
Clinical Development
Advantages & Disadvantages
Product Profile
REGN-1033: Regeneron Pharmaceuticals
Product Description
Clinical Development
Advantages & Disadvantages
Product Profile
LY-2495655: Eli Lilly and Company
Product Description
Clinical Development
Advantages & Disadvantages
Product Profile
Testosterone Enanthate + Finasteride: Endo Pharmaceuticals
Product Description
Clinical Development
Advantages & Disadvantages
Product Profile
BYM338: Novartis AG
Product Description
Clinical Development
Advantages & Disadvantages
Product Profile
Sarconeos: Biophytis
Product Description
Clinical Development
Advantages & Disadvantages
Product Profile
Global Market Scenario for Sarcopenia
Sarcopenia: Country-Wise Market Analysis
7 Major Market Size of Sarcopenia (2013-2023)
Global Market Size by Geography
United States
Market size of Europe
United Kingdom
France
Italy
Spain
Germany
Japan
Market Drivers and Market Barriers for Sarcopenia
Future Prospects for Sarcopenia
Appendix
Report Methodology
Consulting Services
Disclaimer
About DelveInsight

List of Tables

Table 1: Prevalent Population of Sarcopenia in 7MM (2013-2023)
Table 2: Prevalent Population of Sarcopenia in United States (2013-2023)
Table 3: Prevalent Population of Sarcopenia in United Kingdom (2013-2023)
Table 4: Prevalent Population of Sarcopenia in France (2013-2023)
Table 5: Prevalent Population of Sarcopenia in Italy (2013-2023)
Table 6: Prevalent Population of Sarcopenia in Spain (2013-2023)
Table 7: Prevalent Population of Sarcopenia in Germany (2013-2023)
Table 8: Prevalent Population of Sarcopenia in Japan (2013-2023)
Table 9: Pipeline Drugs and Mechanism of Action, 2016
Table 10: Total 7 Major Market size of Sarcopenia in USD Million (2013-2023)
Table 11: United States Market Size of Sarcopenia in USD, Million (2013-2023)
Table 12: United Kingdom Market Size of Sarcopenia in USD, Million (2013-2023)
Table 13: France Market Size of Sarcopenia in USD, Million (2013-2023)
Table 14: Italy Market Size of Sarcopenia in USD, Million (2013-2023)
Table 15: Spain Market Size of Sarcopenia in USD, Million (2013-2023)
Table 16: Germany Market Size of Sarcopenia in USD, Million (2013-2023)
Table 17:Japan Market Size of Sarcopenia in USD, Million (2013-2023)

List of Figures

Figure 1: Mechanisms of Sarcopenia
Figure 2: EWGSOP Screening Algorithm
Figure 3: Prevalent Population of Sarcopenia in 7MM (2013-2023)
Figure 4: Prevalent Population of Sarcopenia in United States (2013-2023)
Figure 5: Prevalent Population of Sarcopenia in United Kingdom (2013-2023)
Figure 6: Prevalent Population of Sarcopenia in France (2013-2023)
Figure 7: Prevalent Population of Sarcopenia in Italy (2013-2023)
Figure 8: Prevalent Population of Sarcopenia in Spain (2013-2023)
Figure 9:Prevalent Population of Sarcopenia in Germany (2013-2023)
Figure 10:Prevalent Population of Sarcopenia in Japan (2013-2023)
Figure 11: Total 7 Major Market Size of Sarcopenia in USD, Million (2013-2023)
Figure 12: United States Market Size of Sarcopenia in USD, Million (2013-2023)
Figure 13: United Kingdom Market Size of Sarcopenia in USD, Million (2013-2023)
Figure 14: France Market Size of Sarcopenia in USD, Million (2013-2023)
Figure 15: Italy Market Size of Sarcopenia in USD, Million (2013-2023)
Figure 16: Spain Market Size of Sarcopenia in USD, Million (2013-2023)
Figure 17: Germany Market Size of Sarcopenia in USD, Million (2013-2023)
Figure 18:Japan Market Size of Sarcopenia in USD, Million (2013-2023)
  • United States Peptide Therapeutics Market Report 2017
    Published: 18-Aug-2017        Price: US 3800 Onwards        Pages: 98
    In this report, the United States Peptide Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rat......
  • United States Hypertrophic Cardiomyopathy Therapeutics Market Report 2017
    Published: 17-Aug-2017        Price: US 3800 Onwards        Pages: 102
    In this report, the United States Hypertrophic Cardiomyopathy Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market ......
  • Raynauds Disease - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 2000 Onwards        Pages: 48
    Raynauds Disease - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Raynauds Disease - Pipeline Review, H2 2017, provides an overview of the Raynauds Disease (Cardiovascular) pipeline landscape. Raynauds disease is a common condition that affects the blood supply to certain parts of the body, usually the fingers and toes. Predisposing factors include age, gender, family history and smok......
  • Batten Disease - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 2000 Onwards        Pages: 53
    Batten Disease - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Batten Disease - Pipeline Review, H2 2017, provides an overview of the Batten Disease (Central Nervous System) pipeline landscape. Batten disease, a rare genetic disorder, belongs to a group of progressive degenerative neurometabolic disorders known as the neuronal ceroid lipofuscinoses. Symptoms of Batten disease usually......
  • Trigeminal Neuralgia - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 2000 Onwards        Pages: 54
    Trigeminal Neuralgia - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Trigeminal Neuralgia - Pipeline Review, H2 2017, provides an overview of the Trigeminal Neuralgia (Central Nervous System) pipeline landscape. Trigeminal neuralgia is a chronic pain condition that affects the trigeminal nerve, which carries sensation from face to brain. Symptoms include spontaneous attacks of pain o......
  • Visceral Pain - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 2000 Onwards        Pages: 55
    Visceral Pain - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Visceral Pain - Pipeline Review, H2 2017, provides an overview of the Visceral Pain (Central Nervous System) pipeline landscape. Visceral pain is a type of nociceptive pain that comes from the internal organs. Symptoms include aches, cramps and diffuse pain. Treatment includes analgesics such as narcotics or NSAIDs and pai......
  • Spinal Muscular Atrophy (SMA) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 2000 Onwards        Pages: 119
    Spinal Muscular Atrophy (SMA) - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Spinal Muscular Atrophy (SMA) - Pipeline Review, H2 2017, provides an overview of the Spinal Muscular Atrophy (SMA) (Central Nervous System) pipeline landscape. Spinal muscular atrophy (SMA) is a genetic disease that attacks nerve cells, called motor neurons, in the spinal cord. These critically important c......
  • Liver Cirrhosis - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 2000 Onwards        Pages: 90
    Liver Cirrhosis - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Liver Cirrhosis - Pipeline Review, H2 2017, provides an overview of the Liver Cirrhosis (Gastrointestinal) pipeline landscape. Cirrhosis is scarring of the liver caused by many forms of liver diseases and conditions, such as hepatitis and chronic alcohol abuse. The scar tissue damages the normal structure of the liver wh......
  • Global Peptide Therapeutics Sales Market Report 2017
    Published: 14-Aug-2017        Price: US 4000 Onwards        Pages: 101
    In this report, the global Peptide Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Peptide Therapeutics for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs